Asimily vs Claroty (2026)
Two healthcare device security specialists that both hold KLAS recognition, split by recency against scale. Asimily is the current top rating, ranked first in the 2026 KLAS Healthcare IoT Security report at 96.6, and its distinguishing capability is contextual vulnerability prioritisation plus pre purchase device evaluation that moves risk assessment ahead of procurement. Claroty is the scale incumbent: its Medigate derived platform reports 20 million plus devices across 2,000 plus hospital facilities with a reported 500 plus protocols, and it has been named Best in KLAS across multiple years rather than one. The honest asymmetry is in the assessment itself, Claroty's record on this index is thinner, graded on fewer axes, so some comparisons rest on its described footprint rather than a graded capability. If your failure mode is the largest proven install base and broadest protocol coverage, start with Claroty. If your failure mode is contextual prioritisation and the current independent number one, start with Asimily.
- The current top independent rating: ranked first in the KLAS 2026 Healthcare IoT Security report at 96.6, the most recent buyer sourced score in the lane.
- Contextual prioritisation as the core capability: each vulnerability is evaluated against the specific device configuration and network environment rather than by CVSS score alone, addressing the unusable raw vulnerability list that defeats hospital teams.
- Capability upstream of procurement: pre purchase device evaluation assesses risk before a device is bought, plus bidirectional CMMS integration graded A on interoperability that connects security to biomedical engineering.
- The largest proven footprint in the lane: a reported 20 million plus devices across 2,000 plus hospital facilities, with device discovery across a reported 500 plus protocols through the Medigate derived platform.
- A long independent track record: named Best in KLAS for Healthcare IoT Security across multiple years, not only a single recent report.
- Purpose built healthcare device security, graded A on setting coverage, spanning IoMT, IoT, and building management systems with clinical context added to threat prioritisation.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Asimily and Claroty are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Asimily | Claroty |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Cybersecurity |
| Founded | 2017 | 2015 |
| Headquarters | Sunnyvale, California, United States | New York, New York |
| Website | asimily.com | claroty.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Asimily its top capability grade on several axes, including HIPAA and BAA Posture, FDA and Regulatory Status and EHR and Interoperability Depth. Set against Claroty, Asimily grades higher on FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Claroty its top capability grade on several axes, including HIPAA and BAA Posture, Security Certifications and Trust Center and EHR and Interoperability Depth. Set against Asimily, Claroty grades higher on Model Supply Chain Disclosure and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Asimily or Claroty?
On the axes where the AI Health Index separates them, Asimily grades higher on FDA and Regulatory Status, and Claroty grades higher on Model Supply Chain Disclosure and Security Certifications and Trust Center. Claroty leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Asimily and Claroty differ most?
The widest separation the AI Health Index records between Asimily and Claroty is on FDA and Regulatory Status, where Asimily grades A and Claroty grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Asimily and Claroty grade the same?
The AI Health Index grades Asimily and Claroty the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Healthcare Cybersecurity page.
Both vendors grade B on AI centrality and are healthcare device security specialists with strong KLAS recognition, so this is a close pairing. A structural caveat matters for reading it: Claroty's record on this index is less fully assessed than Asimily's, carrying graded axes on AI centrality, setting coverage, clinical evidence, and deployment but not yet on model transparency, autonomy, or interoperability, so several axes where Asimily is graded show as not rated for Claroty rather than as a genuine absence of capability.
Asimily's deployment counts and Claroty's device and facility counts are vendor reported. Neither publishes a security attestation such as SOC 2 Type II or ISO 27001, shared across this entire category, nor published pricing.